Deepika's costume in 'Pathaan' song objectionable; she is a supporter of ‘Tukde Tukde gang’: MP home minister

New Delhi, May 5: Actor-turned-politician Kangana Ranaut intended to target an opposition leader but mistakenly ended up attacking her BJP colleague instead. 

A similarity in names - Tejashwi and Tejasvi - was behind Ms Ranaut's fumble. "There's a party of spoilt princes... whether it's Rahul Gandhi who wants to grow potatoes on the Moon, or Tejasvi Surya who does hooliganism and eats fish," she had said.

RJD leader and former Bihar deputy Chief Minister Tejashwi Yadav was supposed to be the original target of her diatribe as one of his videos where he was seen eating fish became a major flashpoint between the BJP and the opposition recently.

Tejasvi Surya, incorrectly referred to by Ms Ranaut during an election rally yesterday, is BJP's Lok Sabha candidate from Bengaluru South constituency in Karnataka.

Meanwhile, Mr Yadav has responded to a clip of Kangana Ranaut's statement. "Ye mohtarma kaun hai?" (Who is this lady?), he posted on X.

Kangana Ranaut has been verbally bashing the Congress party since the BJP fielded her as their Lok Sabha candidate from Himachal Pradesh's Mandi. Congress leaders Vikramaditya Singh - her opponent in Mandi - and Rahul Gandhi have been the main targets on her dartboard.

While addressing a public rally in the Sundernagar area of Mandi Parliamentary Constituency yesterday, Ms Ranaut took a jibe at Mr Singh and Mr Gandhi over dynasty politics and said that both of them have a magic stick for development and talk only about non-practical things.

The Congress hit back saying the 37-year-old actor should first check the facts about her party leaders and speak about dynastic politics. National Media Coordinator for the Congress, Amrit Kaur, also questioned her qualifications on which she got a BJP ticket from Mandi.

The Mandi Lok Sabha constituency will go to polls on June 1, in the seventh phase of the 2024 Lok Sabha elections.

Israeli military tanks have started to go deeper into the Jabalia refugee camp in northern Gaza as part of a ground offensive months after claiming Hamas had been “dismantled” in the area.

Israeli forces are “carpet-bombing” the eastern areas of Jabalia refugee camp in the northern Gaza Strip, killing and wounding several Palestinians, Al-Jazeara reported citing local sources on Sunday.

Israeli military tanks have advanced further into the Jabalia refugee camp, crossing Salah al-Din Street amidst ongoing battles with Hamas fighters, reports added.

Media quoted eyewitnesses as saying that the tanks are surrounding evacuation centers and residential buildings in the densely populated area, leading to mass evacuations and displacement towards the western part of Gaza City.

Also, Israeli drones targeted ambulances near the clinic run by the United Nations Relief and Works Agency for Palestine Refugees (UNRWA) in Jabalia, according to Mahmoud Basal, the spokesperson for the civil defense directorate in Gaza.

Basal stated that emergency crews in Rafah, al-Zaytounm, al-Sabra, and Jabalia have been inundated with distress calls, confirming that these areas were subjected to overnight bombardment.

Shortage of oxygen for patients

Imad Abu Zayda, an emergency doctor in Jabalia, warned of the critical conditions prevailing there due to the recent Israeli aggression in the area.  

“No light due to the lack of fuel and there’s no medical supplement available as Israel has expanded their operation in the area. We have no oxygen to give to patients,” he said.

He added that the majority of those injured are children and women, and the medical team is grappling with limited resources to provide essential care.

All hospitals in the northern Gaza Strip are now out of service, following a warning from the UN about the risk of running out of fuel in hospitals across the region.

Israel’s closure of the Rafah crossing has also prevented aid trucks from entering the area since May 5.

The Jabalia refugee camp, established in 1948 to accommodate Palestinians who were displaced after the Nakba, or catastrophe, which refers to the ethnic cleansing of Palestine in 1948, has become the most densely populated refugee camp in the Gaza Strip.

With over 750,000 Palestinians forcefully displaced, this camp stands as a testament to the birth of Israel in 1948.

Since the start of the Israeli war on the Gaza Strip on October 7, Israeli forces carried out several attacks on Jabilia camp, leaving it in ruins by intense bombardment.

In early February, Israeli forces withdrew from the camp claiming it had destroyed Hamas as a fighting force in the northern areas.

On Saturday, the Israeli military ordered residents of the Jabalia Refugee Camp to evacuate “immediately”, as it prepares to launch military operations against Hamas.

However, the displaced residents have no place to seek refuge, as the UN reports a severe famine in the region.

Since the start of the offensive, the Tel Aviv regime has killed more than 34,971 Palestinians and injured more than 78,641 others, mostly women and children.

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.